Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board, Notice of Meeting, 38142-38143 [2023-12469]

Download as PDF 38142 Federal Register / Vol. 88, No. 112 / Monday, June 12, 2023 / Notices Advisory Committee Management Office, Center for Minority Veterans, and Veterans Health Administration. The Committee will receive public comments from 2 p.m. to 2:15 p.m. EST. The Committee will conduct an afteraction review. Individuals who wish to provide public comments are invited to submit a 1–2-page summary of their comments no later than July 5, 2023 for inclusion in the official meeting record. Members of the public may also submit written statements for the Committee’s review to Mr. Dwayne Campbell, at Dwayne.Campbell3@va.gov. Any member of the public seeking additional information should contact Mr. Dwayne Campbell or Mr. Ronald Sagudan at (202) 461–6191. Date ddrumheller on DSK120RN23PROD with NOTICES1 June June June June 13, 14, 15, 16, 2023 2023 2023 2023 DEPARTMENT OF VETERANS AFFAIRS Dated: June 7, 2023. Jelessa M. Burney, Federal Advisory Committee Management Officer. The Department of Veterans Affairs (VA) gives notice under the Federal Advisory Committee Act, 5 U.S.C. ch. 10, that the Advisory Committee on Women Veterans will conduct a site visit on June 13–16, 2023. The Committee meeting is held with the Veterans Integrated Service Network (VISN) 5: VA Capitol Health Care Network; and with the VA Maryland Health Care System (VAMHCS), 10 North Greene Street, Baltimore, MD 21201–1524 (Room #3a–300) Baltimore, Maryland. The meeting sessions will begin and ends as follows: [FR Doc. 2023–12499 Filed 6–9–23; 8:45 am] BILLING CODE P Advisory Committee on Women Veterans, Notice of Meeting, Amended Time 8:30 8:30 8:30 8:30 Location a.m.–3:00 p.m. Eastern Standard Time (EST) ....... a.m.–3:00 p.m. (EST) .............................................. a.m.–2:30 p.m. (EST) .............................................. a.m.–10:00 a.m. (EST) ............................................ The meeting sessions are open to the public. The purpose of the Committee is to advise the Secretary of Veterans Affairs regarding the needs of women Veterans with respect to health care, rehabilitation, compensation, outreach and other programs and activities administered by VA designed to meet such needs. The Committee makes recommendations to the Secretary regarding such programs and activities. On Tuesday, June 13, the agenda includes overviews of VISN 5’s facilities and program; an overview of VISN 5 services for women Veterans; and an overview of VAMHCS’s facilities, programs and community partners. On Wednesday, June 14, the agenda includes a continuation of briefings on VAMHCS’s programs and services for women Veterans. On Thursday, June 15, the agenda includes a continuation of briefings on VAMHCS’s programs; an overview of Baltimore Regional Office’s business lines and initiatives; and an overview of Baltimore National Cemetery Complex’s services and programs. On Friday, June 16, the Committee will conduct an out-briefing with leadership from VISN 5, VAMHCS, Baltimore Regional Office and Baltimore National Cemetery Complex. The Committee meeting will adjourn at 10:00 a.m. No time will be allocated at this meeting for receiving oral presentations from the public. Interested parties VerDate Sep<11>2014 Individuals who wish to attend the virtual meeting, can do so by dialing into the Microsoft Teams conference information +1 872–701–0185, Phone Conference ID: 550 496 43#. 17:39 Jun 09, 2023 Jkt 259001 VAMHCS VAMHCS VAMHCS VAMHCS Facility/Microsoft Facility/Microsoft Facility/Microsoft Facility/Microsoft should provide written comments for review by the Committee to Ms. Shannon L. Middleton at 00W@ mail.va.gov no later than June 7, 2023. Any member of the public who wishes to participate virtually, please click here: https://teams.microsoft.com/l/ meetup-join/19%3ameeting_ NjU5NTZiZjEtYWZjMy 00Zjg0LThkNzgtYTAyOTM3 MWNhYTBm%40thread.v2/ 0?context=%7b%22Tid%22%3a %22e95f1b23-abaf-45ee-821db7ab251ab3bf%22%2c %22Oid%22%3a%22c7cdff2f-b6ed46b3-b4c5-1e87baf3dc39%22%7d, Meeting ID: 232 290 448 094, Passcode: RknRoB; or call in (audio only) +1 205– 235–3524, 38312534#, phone conference ID: 383 125 34#. Dated: June 7, 2023. Jelessa M. Burney, Federal Advisory Committee Management Officer. [FR Doc. 2023–12444 Filed 6–9–23; 8:45 am] BILLING CODE P DEPARTMENT OF VETERANS AFFAIRS Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board, Notice of Meeting The Department of Veterans Affairs (VA) gives notice under the Federal PO 00000 Frm 00128 Fmt 4703 Sfmt 4703 TEAMS TEAMS TEAMS TEAMS link link link link and and and and call-in call-in call-in call-in information information information information below. below. below. below. Advisory Committee Act, 5 U.S.C. ch. 10, that a meeting of the Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board will be held July 11, 2023, via Webex. The meeting will be held between 3:00 p.m. and 5:00 p.m. EDT. The meeting will be closed to the public from 3:30–5:00 p.m. EDT for the discussion, examination and reference to the research applications and scientific review. Discussions will involve reference to staff and consultant critiques of research proposals. Discussions will deal with scientific merit of each proposal and qualifications of personnel conducting the studies, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Additionally, premature disclosure of research information could significantly obstruct implementation of proposed agency action regarding the research proposals. As provided by Public Law 92–463 subsection 10(d), as amended by Public Law 94–409, closing the committee meeting is in accordance with 5 U.S.C. 552b(c)(6) and (9)(B). The objective of the Board is to provide for the fair and equitable selection of the most meritorious research projects for support by VA research funds and to offer advice for research program officials on program priorities and policies. The ultimate objective of the Board is to ensure the high quality and mission relevance of E:\FR\FM\12JNN1.SGM 12JNN1 Federal Register / Vol. 88, No. 112 / Monday, June 12, 2023 / Notices ddrumheller on DSK120RN23PROD with NOTICES1 VA’s legislatively mandated Biomedical Laboratory and Clinical Science Research and Development programs. Board members advise the Directors of the Biomedical Laboratory and Clinical Sciences Research Services and the Chief Research and Development Officer on the scientific and technical merit, the mission relevance, and the protection of human subjects of Biomedical Laboratory and Clinical Sciences Research and Development proposals. The Board does not consider grants, contracts, or other forms of extramural research. Members of the public may attend the open portion of the meeting. The time VerDate Sep<11>2014 17:39 Jun 09, 2023 Jkt 259001 limited agenda does not enable public comments or presentations. To attend the open portion of the meeting (3:00– 3:30 p.m. EDT), the public may join by dialing the phone number 1–404–397– 1596 and entering the meeting number (access code): 2762 410 8058. Written public comments must be sent to Michael R. Burgio, Ph.D., Designated Federal Officer, Office of Research and Development, Department of Veterans Affairs (14RD), 810 Vermont Avenue NW, Washington, DC 20420, or to Michael.Burgio@va.gov at least five days before the meeting via the email listed above. The written public comments will be shared with the board PO 00000 Frm 00129 Fmt 4703 Sfmt 9990 38143 members. The public may not attend the closed portion of the meeting as disclosure of research information could significantly obstruct implementation of proposed agency action regarding the research proposals (Pub. L. 92–463 subsection 10(d), as amended by Pub. L. 94–409, closing the committee meeting is in accordance with title 5 U.S.C. 552b(c)(6) and (9)(B). Dated: June 7, 2023. LaTonya L. Small, Federal Advisory Committee Management Officer. [FR Doc. 2023–12469 Filed 6–9–23; 8:45 am] BILLING CODE 8320–01–P E:\FR\FM\12JNN1.SGM 12JNN1

Agencies

[Federal Register Volume 88, Number 112 (Monday, June 12, 2023)]
[Notices]
[Pages 38142-38143]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-12469]


-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Joint Biomedical Laboratory Research and Development and Clinical 
Science Research and Development Services Scientific Merit Review 
Board, Notice of Meeting

    The Department of Veterans Affairs (VA) gives notice under the 
Federal Advisory Committee Act, 5 U.S.C. ch. 10, that a meeting of the 
Joint Biomedical Laboratory Research and Development and Clinical 
Science Research and Development Services Scientific Merit Review Board 
will be held July 11, 2023, via Webex. The meeting will be held between 
3:00 p.m. and 5:00 p.m. EDT. The meeting will be closed to the public 
from 3:30-5:00 p.m. EDT for the discussion, examination and reference 
to the research applications and scientific review. Discussions will 
involve reference to staff and consultant critiques of research 
proposals. Discussions will deal with scientific merit of each proposal 
and qualifications of personnel conducting the studies, the disclosure 
of which would constitute a clearly unwarranted invasion of personal 
privacy. Additionally, premature disclosure of research information 
could significantly obstruct implementation of proposed agency action 
regarding the research proposals. As provided by Public Law 92-463 
subsection 10(d), as amended by Public Law 94-409, closing the 
committee meeting is in accordance with 5 U.S.C. 552b(c)(6) and (9)(B).
    The objective of the Board is to provide for the fair and equitable 
selection of the most meritorious research projects for support by VA 
research funds and to offer advice for research program officials on 
program priorities and policies. The ultimate objective of the Board is 
to ensure the high quality and mission relevance of

[[Page 38143]]

VA's legislatively mandated Biomedical Laboratory and Clinical Science 
Research and Development programs.
    Board members advise the Directors of the Biomedical Laboratory and 
Clinical Sciences Research Services and the Chief Research and 
Development Officer on the scientific and technical merit, the mission 
relevance, and the protection of human subjects of Biomedical 
Laboratory and Clinical Sciences Research and Development proposals. 
The Board does not consider grants, contracts, or other forms of 
extramural research.
    Members of the public may attend the open portion of the meeting. 
The time limited agenda does not enable public comments or 
presentations. To attend the open portion of the meeting (3:00-3:30 
p.m. EDT), the public may join by dialing the phone number 1-404-397-
1596 and entering the meeting number (access code): 2762 410 8058.
    Written public comments must be sent to Michael R. Burgio, Ph.D., 
Designated Federal Officer, Office of Research and Development, 
Department of Veterans Affairs (14RD), 810 Vermont Avenue NW, 
Washington, DC 20420, or to [email protected] at least five days 
before the meeting via the email listed above. The written public 
comments will be shared with the board members. The public may not 
attend the closed portion of the meeting as disclosure of research 
information could significantly obstruct implementation of proposed 
agency action regarding the research proposals (Pub. L. 92-463 
subsection 10(d), as amended by Pub. L. 94-409, closing the committee 
meeting is in accordance with title 5 U.S.C. 552b(c)(6) and (9)(B).

    Dated: June 7, 2023.
LaTonya L. Small,
Federal Advisory Committee Management Officer.
[FR Doc. 2023-12469 Filed 6-9-23; 8:45 am]
BILLING CODE 8320-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.